Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Apr 15;323 ( Pt 2)(Pt 2):451-6.
doi: 10.1042/bj3230451.

Diadenosine polyphosphate-stimulated gluconeogenesis in isolated rat proximal tubules

Affiliations

Diadenosine polyphosphate-stimulated gluconeogenesis in isolated rat proximal tubules

M Edgecombe et al. Biochem J. .

Abstract

Diadenosine polyphosphates released into the extracellular environment influence a variety of metabolic and other cellular activities in a wide range of target tissues. Here we have studied the impact of these novel nucleotides on gluconeogenesis in isolated rat proximal tubules. Gluconeogenesis was stimulated following exposure of isolated proximal tubules to a range of adenine-containing nucleotides including ADP, ATP, Ap3A, Ap4A, Ap5A and Ap6A. The concentration-dependence of ATP-, Ap3A- and Ap4A-mediated stimulation of gluconeogenesis was similar and was consistent with a role for these agents in the physiological control of renal metabolism. Nucleotide-stimulated gluconeogenesis was diminished in the presence of agents that interfere with phospholipase C activation or intracellular Ca2+ metabolism, indicative of a role for polyphosphoinositide-mediated Ca2+ mobilization in the mechanism of action of ATP, Ap3A and Ap4A. The characteristics of binding of [2-3H]Ap4A to renal plasma-membrane preparations suggest that Ap4A mediates its effects on proximal tubule gluconeogenesis via interaction with P2y-like purinoceptor(s) also recognized by extracellular ATP.

PubMed Disclaimer

References

    1. Hypertension. 1995 Dec;26(6 Pt 1):899-904 - PubMed
    1. Br J Pharmacol. 1995 Sep;116(1):1619-27 - PubMed
    1. Br J Pharmacol. 1995 Nov;116(5):2413-6 - PubMed
    1. Biochem J. 1996 Mar 1;314 ( Pt 2):687-93 - PubMed
    1. Br J Pharmacol. 1996 Feb;117(4):698-702 - PubMed

Publication types